Loading clinical trials...
Loading clinical trials...
This study was designed to determine the optimal dose of remifentanil that can prevent the complications associated with the removal of LMA without delaying emergence.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sangjin Park
NCT07356583 · Enterovirus, Clinical Syndrome, and more
NCT06722365 · Respiratory Complication, Fetal Lung Imaging
NCT06719258 · Humidifier Lung, Mechanical Fragility, and more
NCT06744790 · Post Surgical Respiratory Failure, Respiratory Complication
NCT06412081 · Respiratory Complication
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions